COVID-19 – Omicron: resistant to most monoclonal antibodies but neutralized by a booster dose
The Omicron variant was detected for the first time in South Africa in November 2021 and has since spread to many countries.…
The Omicron variant was detected for the first time in South Africa in November 2021 and has since spread to many countries.…
Synopsis : Novartis and Molecular Partners announced that Part A of the EMPATHY clinical trial(1) that compared single intravenous doses of ensovibep,…
Synopsis : Bayer AG and Mammoth Biosciences, Inc., which is harnessing the diversity of nature to power the next-generation CRISPR products, today…
Synopsis : Amgen and Arrakis Therapeutics today announced a research collaboration focused on the discovery and development of RNA degrader therapeutics against…
Synopsis : With this NDA approval, the company looks forward to bringing this new medicine to physicians and their patients for the…
Synopsis : Bharat Biotech has sought from the Drugs Controller General of India (DCGI) regular market approval for its COVID-19 vaccine Covaxin’,…
Summary : On the brink of two major approvals this year, Eli Lilly is laser-focused on diabetes and dementia. One market is…
Summary : Order up. Shortly after topping off supplies of COVID-19 drugs from Pfizer and GlaxoSmithKline, the U.S. has asked for a…
Summary : -The partnership between Oxford University and SEEQC promises to accelerate the use of quantum computing within pharmaceutical research in order…
Summary : AstraZeneca (AZ) has reported preliminary data from a trial it conducted on its COVID-19 booster shot, Vaxzevria. The results from…